314 related articles for article (PubMed ID: 23640887)
1. Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.
Basurto-Islas G; Grundke-Iqbal I; Tung YC; Liu F; Iqbal K
J Biol Chem; 2013 Jun; 288(24):17495-507. PubMed ID: 23640887
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection.
Wang X; Blanchard J; Grundke-Iqbal I; Wegiel J; Deng HX; Siddique T; Iqbal K
Acta Neuropathol; 2014 Feb; 127(2):243-56. PubMed ID: 24136402
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury.
Hu W; Tung YC; Zhang Y; Liu F; Iqbal K
J Alzheimers Dis; 2018; 64(3):709-722. PubMed ID: 29889065
[TBL] [Abstract][Full Text] [Related]
5. Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.
Arif M; Kazim SF; Grundke-Iqbal I; Garruto RM; Iqbal K
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1144-9. PubMed ID: 24395787
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease.
Tanimukai H; Grundke-Iqbal I; Iqbal K
Am J Pathol; 2005 Jun; 166(6):1761-71. PubMed ID: 15920161
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.
Arnaud L; Chen S; Liu F; Li B; Khatoon S; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2011 Sep; 585(17):2653-9. PubMed ID: 21806989
[TBL] [Abstract][Full Text] [Related]
8. Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction.
Zhang X; Zou L; Meng L; Xiong M; Pan L; Chen G; Zheng Y; Xiong J; Wang Z; Duong DM; Zhang Z; Cao X; Wang T; Tang L; Ye K; Zhang Z
Elife; 2021 May; 10():. PubMed ID: 34018922
[TBL] [Abstract][Full Text] [Related]
9. The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer's Disease.
Song M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142134
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Tau Hyperphosphorylation Involving Lysosomal Enzyme Asparagine Endopeptidase in a Mouse Model of Brain Ischemia.
Basurto-Islas G; Gu JH; Tung YC; Liu F; Iqbal K
J Alzheimers Dis; 2018; 63(2):821-833. PubMed ID: 29689717
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A.
Chasseigneaux S; Clamagirand C; Huguet L; Gorisse-Hussonnois L; Rose C; Allinquant B
BMC Neurosci; 2014 Jun; 15():82. PubMed ID: 24981783
[TBL] [Abstract][Full Text] [Related]
12. Effects of Porphyromonas gingivalis and Its Underlying Mechanisms on Alzheimer-Like Tau Hyperphosphorylation in Sprague-Dawley Rats.
Tang Z; Liang D; Cheng M; Su X; Liu R; Zhang Y; Wu H
J Mol Neurosci; 2021 Jan; 71(1):89-100. PubMed ID: 32557144
[TBL] [Abstract][Full Text] [Related]
13. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic strategies for neurodegenerative disease.
Tanimukai H; Kudo T; Tanaka T; Grundke-Iqbal I; Iqbal K; Takeda M
Psychogeriatrics; 2009 Jun; 9(2):103-9. PubMed ID: 19604333
[TBL] [Abstract][Full Text] [Related]
16. Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine.
Chohan MO; Khatoon S; Iqbal IG; Iqbal K
FEBS Lett; 2006 Jul; 580(16):3973-9. PubMed ID: 16806196
[TBL] [Abstract][Full Text] [Related]
17. Silencing PP2A inhibitor by lenti-shRNA interference ameliorates neuropathologies and memory deficits in tg2576 mice.
Liu GP; Wei W; Zhou X; Shi HR; Liu XH; Chai GS; Yao XQ; Zhang JY; Peng CX; Hu J; Li XC; Wang Q; Wang JZ
Mol Ther; 2013 Dec; 21(12):2247-57. PubMed ID: 23922015
[TBL] [Abstract][Full Text] [Related]
18. Animal models of the sporadic form of Alzheimer's disease: focus on the disease and not just the lesions.
Iqbal K; Bolognin S; Wang X; Basurto-Islas G; Blanchard J; Tung YC
J Alzheimers Dis; 2013; 37(3):469-74. PubMed ID: 23948903
[TBL] [Abstract][Full Text] [Related]
19. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
[TBL] [Abstract][Full Text] [Related]
20. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
